EVOK
$4.43
Evoke Pharma
($.30)
(6.34%)
EVOK
Earnings Whisper ®
N/A
3rd Quarter September 2020
Consensus:  ($0.10)
Revenue:  $0.00 Mil
Thursday
Nov 5
8:30 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when EVOK reports earnings?
Beat
Meet
Miss

Where is EVOK's stock price going from here?
Up
Flat
Down
Stock chart of EVOK
Analysts
Summary of analysts' recommendations for EVOK
Score
Grade
Pivots
Resistance
$5.15
$5.00
$4.71

$4.56

Support
$4.27
$4.12
$3.83
Tweet
Growth
Description
Evoke Pharma, Inc. is a specialty pharmaceutical company focused primarily on the development of drugs to treat gastrointestinal disorders and diseases. The Company's lead product candidate, EVK-001, is in late stage clinical testing which is intended for the treatment of diabetic gastroparesis. Evoke Pharma, Inc. is based in San Diego, California.
Peers
InterCeptRegeneron PharmaceuticalsBioMarin PharmaceuticalVertex PharmaceuticalsJohnson & JohnsonZoetisUltragenyx PharmaceuticalBristol-Myers SquibbCatalentMerck & Co.